BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7880838)

  • 21. Induction of cell death in murine fibroblasts by a c-myc promoter binding protein.
    Ray RB
    Cell Growth Differ; 1995 Sep; 6(9):1089-96. PubMed ID: 8519685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. X-ray crystallographic studies of eukaryotic transcription initiation factors.
    Burley SK
    Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):483-9. PubMed ID: 8735270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequence-dependent solution structure and motions of 13 TATA/TBP (TATA-box binding protein) complexes.
    Strahs D; Barash D; Qian X; Schlick T
    Biopolymers; 2003 Jun; 69(2):216-43. PubMed ID: 12767124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter.
    Duyao MP; Buckler AJ; Sonenshein GE
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4727-31. PubMed ID: 2191300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional binding of the "TATA" box binding component of transcription factor TFIID to the -30 region of TATA-less promoters.
    Wiley SR; Kraus RJ; Mertz JE
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5814-8. PubMed ID: 1321424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Core promoter-specific function of a mutant transcription factor TFIID defective in TATA-box binding.
    Martinez E; Zhou Q; L'Etoile ND; Oelgeschläger T; Berk AJ; Roeder RG
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11864-8. PubMed ID: 8524864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of a yeast TBP/TATA-box complex.
    Kim Y; Geiger JH; Hahn S; Sigler PB
    Nature; 1993 Oct; 365(6446):512-20. PubMed ID: 8413604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription.
    Bellorini M; Moncollin V; D'Incalci M; Mongelli N; Mantovani R
    Nucleic Acids Res; 1995 May; 23(10):1657-63. PubMed ID: 7784168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells.
    Stewart MJ; Litz-Jackson S; Burgess GS; Williamson EA; Leibowitz DS; Boswell HS
    Leukemia; 1995 Sep; 9(9):1499-507. PubMed ID: 7658719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional significance of the TATA element major groove in transcription initiation by RNA polymerase II.
    Lee DK; Wang KC; Roeder RG
    Nucleic Acids Res; 1997 Nov; 25(21):4338-45. PubMed ID: 9336466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning and characterization of a human c-myc promoter-binding protein.
    Ray R; Miller DM
    Mol Cell Biol; 1991 Apr; 11(4):2154-61. PubMed ID: 2005901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of Myc transactivation by the TATA binding protein in promoter-reporter assays.
    Barrett JF; Lee LA; Dang CV
    BMC Biochem; 2005 May; 6():7. PubMed ID: 15876353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of TFIID in the minor groove of the TATA element.
    Lee DK; Horikoshi M; Roeder RG
    Cell; 1991 Dec; 67(6):1241-50. PubMed ID: 1760848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCAAT-box binding protein NF-Y (CBF, CP1) recognizes the minor groove and distorts DNA.
    Ronchi A; Bellorini M; Mongelli N; Mantovani R
    Nucleic Acids Res; 1995 Nov; 23(22):4565-72. PubMed ID: 8524643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of major and minor groove DNA interactions by the zinc fingers of Xenopus transcription factor IIIA.
    McBryant SJ; Gedulin B; Clemens KR; Wright PE; Gottesfeld JM
    Nucleic Acids Res; 1996 Jul; 24(13):2567-74. PubMed ID: 8692697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of a novel triple helix-forming oligodeoxyribonucleotide directed to the major promoter of the c-myc gene.
    McGuffie EM; Catapano CV
    Nucleic Acids Res; 2002 Jun; 30(12):2701-9. PubMed ID: 12060688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels.
    Postel EH; Flint SJ; Kessler DJ; Hogan ME
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8227-31. PubMed ID: 1896473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor and gamma-interferon repress transcription from the c-myc P2 promoter by reducing E2F binding activity.
    Carlberg AL; Moberg KH; Hall DJ
    Int J Oncol; 1999 Jul; 15(1):121-6. PubMed ID: 10375604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation.
    Chen X; Farmer G; Zhu H; Prywes R; Prives C
    Genes Dev; 1993 Oct; 7(10):1837-49. PubMed ID: 8405994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic simulations of 13 TATA variants refine kinetic hypotheses of sequence/activity relationships.
    Qian X; Strahs D; Schlick T
    J Mol Biol; 2001 May; 308(4):681-703. PubMed ID: 11350169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.